WO2004085424A1 - スルホキシド誘導体またはその塩のアモルファスの製造方法 - Google Patents
スルホキシド誘導体またはその塩のアモルファスの製造方法 Download PDFInfo
- Publication number
- WO2004085424A1 WO2004085424A1 PCT/JP2004/003525 JP2004003525W WO2004085424A1 WO 2004085424 A1 WO2004085424 A1 WO 2004085424A1 JP 2004003525 W JP2004003525 W JP 2004003525W WO 2004085424 A1 WO2004085424 A1 WO 2004085424A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methoxypropoxy
- salt
- benzimidazole
- methylpyridine
- amorphous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2516600A CA2516600C (en) | 2003-03-24 | 2004-03-17 | Process for production of sulfoxide proton pump inhibitors in the amorphous state |
JP2005504007A JP4787017B2 (ja) | 2003-03-24 | 2004-03-17 | スルホキシド誘導体またはその塩のアモルファスの製造方法 |
US10/546,994 US20060178406A1 (en) | 2003-03-24 | 2004-03-17 | Process for production of sulfoxide derivatives or salts thereof in the amorphous state |
DE602004032524T DE602004032524D1 (de) | 2003-03-24 | 2004-03-17 | Verfahren zur herstellung von amorphem rabeprazole-natrium-salz |
AT04721289T ATE508124T1 (de) | 2003-03-24 | 2004-03-17 | Verfahren zur herstellung von amorphem rabeprazole-natrium-salz |
AU2004224042A AU2004224042B2 (en) | 2003-03-24 | 2004-03-17 | Process for production of sulfoxide derivatives or salts thereof in the amorphous state |
EP04721289A EP1607395B1 (en) | 2003-03-24 | 2004-03-17 | Process for the preparation of amorphous rabeprazole sodium salt |
IL169791A IL169791A (en) | 2003-03-24 | 2005-07-20 | Process for preparing an amorphous substance of 2-{[4-(3-methoxypropoxy)-3-methylpyridine-2-yl]methylsulfinyl}-1h-benzimidazole sodium salt |
US11/939,418 US7754887B2 (en) | 2003-03-24 | 2007-11-13 | Process for production of sulfoxide derivatives or salts thereof in the amorphous state |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-081261 | 2003-03-24 | ||
JP2003081261 | 2003-03-24 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10546994 A-371-Of-International | 2004-03-17 | ||
US11/939,418 Continuation US7754887B2 (en) | 2003-03-24 | 2007-11-13 | Process for production of sulfoxide derivatives or salts thereof in the amorphous state |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004085424A1 true WO2004085424A1 (ja) | 2004-10-07 |
Family
ID=33094891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/003525 WO2004085424A1 (ja) | 2003-03-24 | 2004-03-17 | スルホキシド誘導体またはその塩のアモルファスの製造方法 |
Country Status (11)
Country | Link |
---|---|
US (2) | US20060178406A1 (ja) |
EP (1) | EP1607395B1 (ja) |
JP (1) | JP4787017B2 (ja) |
KR (1) | KR100714375B1 (ja) |
CN (1) | CN100364987C (ja) |
AT (1) | ATE508124T1 (ja) |
AU (1) | AU2004224042B2 (ja) |
CA (1) | CA2516600C (ja) |
DE (1) | DE602004032524D1 (ja) |
IL (1) | IL169791A (ja) |
WO (1) | WO2004085424A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007023393A2 (en) * | 2005-08-02 | 2007-03-01 | Medichem, S.A. | Novel processes for the production of amorphous rabeprazole sodium |
US7683177B2 (en) | 2003-06-10 | 2010-03-23 | Teva Pharmaceutical Industries Ltd | Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
US7829718B2 (en) | 2004-08-06 | 2010-11-09 | Eisai R&D Management Co., Ltd. | Salts of benzimidazole derivative with amines and process for manufacturing the same |
EP2343289A1 (en) * | 1999-06-17 | 2011-07-13 | Takeda Pharmaceutical Company Limited | Amorphous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole as anti-ulcer agent |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1392813B1 (it) * | 2009-02-06 | 2012-03-23 | Dipharma Francis Srl | Forme cristalline di dexlansoprazolo |
AU2011234001B2 (en) * | 2010-03-31 | 2014-08-28 | Sun Pharmaceutical Industries Limited | Salts of dexlansoprazole and their preparation |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59167587A (ja) * | 1983-03-04 | 1984-09-21 | アクチエボラゲツト・ヘツスレ | オメプラゾ−ル化合物 |
JPS646270A (en) * | 1986-11-13 | 1989-01-10 | Eisai Co Ltd | Pyridine derivative and remedy for ulceration containing the same |
JPH08176113A (ja) * | 1993-11-12 | 1996-07-09 | Dainippon Pharmaceut Co Ltd | 2−スルフィニルニコチンアミド誘導体及びその中間体並びにそれを有効成分とする消化性潰瘍治療薬 |
JP2000143659A (ja) * | 1998-11-16 | 2000-05-26 | Eisai Co Ltd | スルホキシド誘導体・アセトン錯体およびその製造法 |
JP2001122783A (ja) * | 1999-06-17 | 2001-05-08 | Takeda Chem Ind Ltd | ベンズイミダゾール化合物の結晶 |
JP2001507025A (ja) * | 1996-12-20 | 2001-05-29 | アストラ・アクチエボラーグ | 新規な化合物形態 |
JP2002114779A (ja) * | 2000-08-04 | 2002-04-16 | Takeda Chem Ind Ltd | ベンズイミダゾール化合物の塩およびその用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI90544C (fi) * | 1986-11-13 | 1994-02-25 | Eisai Co Ltd | Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi |
TWI289557B (en) * | 1999-06-17 | 2007-11-11 | Takeda Chemical Industries Ltd | A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole |
CA2290893C (en) * | 1999-11-16 | 2007-05-01 | Bernard Charles Sherman | Magnesium omeprazole |
EP1706397A4 (en) | 2000-05-15 | 2007-08-01 | Ranbaxy Lab Ltd | AMORPHOUS FORM OF OMEPRAZOLE SALTS |
WO2004002982A2 (en) * | 2002-06-27 | 2004-01-08 | Dr. Reddy's Laboratories Limited | A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
EP2596792A1 (en) * | 2002-10-16 | 2013-05-29 | Takeda Pharmaceutical Company Limited | Stable solid preparations |
US7507829B2 (en) * | 2002-12-19 | 2009-03-24 | Teva Pharmaceuticals Industries, Ltd | Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
-
2004
- 2004-03-17 CN CNB2004800055704A patent/CN100364987C/zh not_active Expired - Fee Related
- 2004-03-17 JP JP2005504007A patent/JP4787017B2/ja not_active Expired - Fee Related
- 2004-03-17 KR KR1020057015526A patent/KR100714375B1/ko not_active IP Right Cessation
- 2004-03-17 AT AT04721289T patent/ATE508124T1/de not_active IP Right Cessation
- 2004-03-17 DE DE602004032524T patent/DE602004032524D1/de not_active Expired - Lifetime
- 2004-03-17 US US10/546,994 patent/US20060178406A1/en not_active Abandoned
- 2004-03-17 AU AU2004224042A patent/AU2004224042B2/en not_active Ceased
- 2004-03-17 CA CA2516600A patent/CA2516600C/en not_active Expired - Fee Related
- 2004-03-17 WO PCT/JP2004/003525 patent/WO2004085424A1/ja active Application Filing
- 2004-03-17 EP EP04721289A patent/EP1607395B1/en not_active Expired - Lifetime
-
2005
- 2005-07-20 IL IL169791A patent/IL169791A/en not_active IP Right Cessation
-
2007
- 2007-11-13 US US11/939,418 patent/US7754887B2/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59167587A (ja) * | 1983-03-04 | 1984-09-21 | アクチエボラゲツト・ヘツスレ | オメプラゾ−ル化合物 |
JPS646270A (en) * | 1986-11-13 | 1989-01-10 | Eisai Co Ltd | Pyridine derivative and remedy for ulceration containing the same |
JPH08176113A (ja) * | 1993-11-12 | 1996-07-09 | Dainippon Pharmaceut Co Ltd | 2−スルフィニルニコチンアミド誘導体及びその中間体並びにそれを有効成分とする消化性潰瘍治療薬 |
JP2001507025A (ja) * | 1996-12-20 | 2001-05-29 | アストラ・アクチエボラーグ | 新規な化合物形態 |
JP2000143659A (ja) * | 1998-11-16 | 2000-05-26 | Eisai Co Ltd | スルホキシド誘導体・アセトン錯体およびその製造法 |
JP2001122783A (ja) * | 1999-06-17 | 2001-05-08 | Takeda Chem Ind Ltd | ベンズイミダゾール化合物の結晶 |
JP2002114779A (ja) * | 2000-08-04 | 2002-04-16 | Takeda Chem Ind Ltd | ベンズイミダゾール化合物の塩およびその用途 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2343289A1 (en) * | 1999-06-17 | 2011-07-13 | Takeda Pharmaceutical Company Limited | Amorphous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole as anti-ulcer agent |
US7683177B2 (en) | 2003-06-10 | 2010-03-23 | Teva Pharmaceutical Industries Ltd | Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
US7829718B2 (en) | 2004-08-06 | 2010-11-09 | Eisai R&D Management Co., Ltd. | Salts of benzimidazole derivative with amines and process for manufacturing the same |
US8053580B2 (en) | 2004-08-06 | 2011-11-08 | Eisal R&D Management Co., Ltd. | Salts of benzimidazole derivative with amines and process for manufacturing the same |
WO2007023393A2 (en) * | 2005-08-02 | 2007-03-01 | Medichem, S.A. | Novel processes for the production of amorphous rabeprazole sodium |
WO2007023393A3 (en) * | 2005-08-02 | 2007-07-19 | Medichem Sa | Novel processes for the production of amorphous rabeprazole sodium |
Also Published As
Publication number | Publication date |
---|---|
US7754887B2 (en) | 2010-07-13 |
CA2516600C (en) | 2011-04-05 |
CA2516600A1 (en) | 2004-10-07 |
ATE508124T1 (de) | 2011-05-15 |
KR100714375B1 (ko) | 2007-05-02 |
KR20050108360A (ko) | 2005-11-16 |
US20060178406A1 (en) | 2006-08-10 |
EP1607395A4 (en) | 2009-06-03 |
EP1607395B1 (en) | 2011-05-04 |
US20080214828A1 (en) | 2008-09-04 |
AU2004224042B2 (en) | 2010-03-25 |
EP1607395A1 (en) | 2005-12-21 |
DE602004032524D1 (de) | 2011-06-16 |
IL169791A (en) | 2012-04-30 |
AU2004224042A1 (en) | 2004-10-07 |
JPWO2004085424A1 (ja) | 2006-06-29 |
CN1756751A (zh) | 2006-04-05 |
CN100364987C (zh) | 2008-01-30 |
JP4787017B2 (ja) | 2011-10-05 |
IL169791A0 (en) | 2007-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101137371B (zh) | 制备兰索拉唑的方法 | |
KR20100124710A (ko) | 레날리도미드의 제조 | |
NZ332154A (en) | Process for the production of a magnesium salt of a substituted sulphinyl benzimidazole | |
EP2265605A1 (en) | Dexlansoprazole process and polymorphs | |
RU2008127354A (ru) | Полиморфы модулятора рецептора андрогена | |
EP2030973A1 (en) | Process for preparing 2-sulfinyl-1H-benzimidazoles | |
US7754887B2 (en) | Process for production of sulfoxide derivatives or salts thereof in the amorphous state | |
WO2010129636A2 (en) | Lenalidomide polymorph | |
JP2007527924A (ja) | 非晶質バルサルタンの製造方法 | |
JP2001039975A (ja) | スルホキシド誘導体の結晶およびその製造法 | |
RU2197486C2 (ru) | Усовершенствованный способ синтеза 5-метокси-2-[(4-метокси-3,5-диметил-2-пиридил)метил]сульфинил-1н-бензимидазола | |
CN110606850A (zh) | 一种3-苯并[4,5]咪唑[1,2-a]吡嗪-1-胺类化合物及其制备方法和应用 | |
WO2011004387A2 (en) | Process for the preparation of dexlansoprazole polymorphic forms | |
JP2008545768A (ja) | オメプラゾールナトリウムの結晶性溶媒和物 | |
US20090198066A1 (en) | Amorphous esomeprazole hydrate | |
WO2008017020A2 (en) | Process for preparing proton pump inhibitors | |
US20050272802A1 (en) | Process for preparing form I of tegaserod maleate | |
CN106831853B (zh) | 7-乙基-10-o-叔丁基二苯基硅基喜树碱-20-o-甘氨酸盐酸盐的制备工艺 | |
CN115703745A (zh) | 一种恩杂鲁胺的制备方法 | |
WO2011095984A1 (en) | A process for the preparation of amorphous esomeprazole | |
CN108794450A (zh) | 制备无定型右旋兰索拉唑的方法 | |
CN107857756A (zh) | 一种艾普拉唑镁晶型及其制备方法 | |
WO2017114898A1 (en) | Process for the preparation of pantoprazole sodium sesquihydrate | |
Sadaphal et al. | World Journal of Pharmaceutical Sciences |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005504007 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 169791 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2516600 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004721289 Country of ref document: EP Ref document number: 1020057015526 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2006178406 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10546994 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20048055704 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004224042 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2355/CHENP/2005 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2004224042 Country of ref document: AU Date of ref document: 20040317 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004224042 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057015526 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2004721289 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10546994 Country of ref document: US |